Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

ConditionsMulti-omics Technique Nasopharyngeal Carcinoma Recurrent and Metastatic Nasopharyngeal Carcinoma Efficacy of Chemoradiotherapy and Immunotherapy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-70

SponsorSun Yat-sen University

About this trial

The observational clinical study will recruit 50 recurrent and/or metastatic nasopharyngeal carcinoma (r/mNPC) patients, to investigate the prediction values of multi-omics technique for the efficacy of chemoradiotherapy combined with immunotherapy.

Eligibility criteria

Qualifiers

Recurrent or metastatic nasopharyngeal carcinoma patients

All genders，range from 18～70 years old

ECOG score 0 ~ 1

Inform consent form

Disqualifiers

Have or are suffering from other malignant tumors;

Participating in other clinical trials;

Drug or alcohol addition;

Do not have full capacity for civil acts;

Trial design

Treatments tested in this trial

cisplatin-based chemoradiotherapy combined with immunotherapy

Treatment groups

50 Participants

are divided into 1 treatment group

Sponsors and collaborators

Sun Yat-sen University

Lead sponsor

Source ClinicalTrials.gov